Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shihan Zhou

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
BMC Cancer|October 18, 2024
Pyrotinib combined with metronomic etoposide in heavily pretreated HER2-positive metastatic breast cancer: a single-arm, phase II studyJiaxuan Liu, Maiyue He, Mingxia Jiang, et al.
NPJ Science of Food|November 17, 2025
Dietary choline-derived Trimethylamine N-oxide impairs hippocampal neuronal function via PANoptosis activationYanqing Wang, Shuang Shen, Yan Sun, et al.
BMC Medicine|April 29, 2026
Mitoxantrone hydrochloride liposome (Lipo-MIT) combined with capecitabine in HER2-negative advanced breast cancer: a dose-escalation, phase I studyJiaxuan Liu, Mingxia Jiang, Mengqi Zhang, et al.
Heliyon|August 16, 2024
Mechanism of Yishen Chuchan decoction intervention of Parkinson's disease based on network pharmacology and experimental verificationDong Di, Chencheng Zhang, Suping Sun, et al.
BMC Cancer|July 22, 2024
Neoadjuvant inetetamab and pertuzumab with taxanes and carboplatin (TCbIP) In locally advanced HER2-positive breast cancer: a prospective cohort study with propensity-matched analysisMingxia Jiang, Yue Chai, Jiaxuan Liu, et al.
Cancer Biology & Medicine|September 13, 2024
Clinical benefit and safety profile of cross-line therapy with CDK4/6 inhibitors: a retrospective study of HR+/HER2- advanced breast cancerQi Zhao, Mingxia Jiang, Jiaxuan Liu, et al.
The Oncologist|February 6, 2026
Efficacy of neoadjuvant endocrine therapy with CDK4/6 inhibitors in locally advanced breast cancerMengqi Zhang, Mingxiao Li, Shihan Zhou, et al.
Food Chemistry: X|April 22, 2026
Identification of key volatiles affecting the flavour of Hainan 'Shanyou' (<i>Camellia hainanica</i>) oil by GC-MSYuanhao Ding, Shihan Zhou, Mengyu Zhang, et al.
Frontiers in Pharmacology|August 8, 2025
The role of trimethylamine N-oxide in disease pathogenesis and the therapeutic potential of traditional Chinese medicineZizhen Qin, Wanning Wu, Xinyu Yang, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
BMC Cancer|October 18, 2024
Pyrotinib combined with metronomic etoposide in heavily pretreated HER2-positive metastatic breast cancer: a single-arm, phase II studyJiaxuan Liu, Maiyue He, Mingxia Jiang, et al.
NPJ Science of Food|November 17, 2025
Dietary choline-derived Trimethylamine N-oxide impairs hippocampal neuronal function via PANoptosis activationYanqing Wang, Shuang Shen, Yan Sun, et al.
BMC Medicine|April 29, 2026
Mitoxantrone hydrochloride liposome (Lipo-MIT) combined with capecitabine in HER2-negative advanced breast cancer: a dose-escalation, phase I studyJiaxuan Liu, Mingxia Jiang, Mengqi Zhang, et al.
Heliyon|August 16, 2024
Mechanism of Yishen Chuchan decoction intervention of Parkinson's disease based on network pharmacology and experimental verificationDong Di, Chencheng Zhang, Suping Sun, et al.
BMC Cancer|July 22, 2024
Neoadjuvant inetetamab and pertuzumab with taxanes and carboplatin (TCbIP) In locally advanced HER2-positive breast cancer: a prospective cohort study with propensity-matched analysisMingxia Jiang, Yue Chai, Jiaxuan Liu, et al.
Cancer Biology & Medicine|September 13, 2024
Clinical benefit and safety profile of cross-line therapy with CDK4/6 inhibitors: a retrospective study of HR+/HER2- advanced breast cancerQi Zhao, Mingxia Jiang, Jiaxuan Liu, et al.
The Oncologist|February 6, 2026
Efficacy of neoadjuvant endocrine therapy with CDK4/6 inhibitors in locally advanced breast cancerMengqi Zhang, Mingxiao Li, Shihan Zhou, et al.
Food Chemistry: X|April 22, 2026
Identification of key volatiles affecting the flavour of Hainan 'Shanyou' (<i>Camellia hainanica</i>) oil by GC-MSYuanhao Ding, Shihan Zhou, Mengyu Zhang, et al.
Frontiers in Pharmacology|August 8, 2025
The role of trimethylamine N-oxide in disease pathogenesis and the therapeutic potential of traditional Chinese medicineZizhen Qin, Wanning Wu, Xinyu Yang, et al.
Pageof 3